Skip to main content
ARIX BIOSCIENCE PLC logo

ARIX BIOSCIENCE PLC - Investor Relations & Filings

Delisted Feb 2024 · Acquired / Merged Acquired / Merged The company was acquired by or merged into another entity, so its shares stopped trading independently.
Ticker · ARIX ISIN · GB00BD045071 LEI · 213800OVT3AHQCXNIX43 IL Financial and insurance activities
Open in API
Filings indexed 556 across all filing types
Latest filing 2022-06-07 AGM Information
Country GB United Kingdom
Listing IL ARIX

About ARIX BIOSCIENCE PLC

https://www.arixbioscience.com/

Arix Bioscience plc is a global venture capital company that specializes in the biotechnology and life sciences sectors. The firm's primary activity involves investing in and building innovative biotech companies, providing capital and strategic support from early stages, including seed, preclinical, and clinical development. Arix focuses on identifying and nurturing breakthrough advances in life sciences to accelerate the development of new medical technologies and therapies. According to public information, the company has entered into a process of liquidation.

Recent filings

Filing Released Lang Actions
Result of Annual General Meeting 2022
AGM Information Classification · 99% confidence The document explicitly states 'Result of Annual General Meeting 2022' in the title and body. It details that 'all resolutions as set out on the notice of meeting were duly passed by way of a poll,' followed by a table showing the detailed voting results for each resolution (Ordinary and Special). This content directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it relates to the AGM, the core content is the *result* of the voting, not the presentation materials (AGM-R) or the proxy solicitation (PSI).
2022-06-07 English
Group of companies' accounts made up to 2021-12-31
Annual Report Classification · 100% confidence Reclassified Regulatory Filings -> Annual Report: UK Companies House statutory annual accounts (title rule; PDF present but not yet markdown-processed, content classification pending). 2026-07-03.
2022-05-20 English
Arix Annual Report ESEF-T01
Annual Report (ESEF) Classification · 100% confidence FY 2021
2022-05-19 English
Letter to Shareholders - Electronic Communications
Regulatory Filings Classification · 99% confidence The document is a letter dated May 12, 2022, addressed to shareholders of Arix Bioscience Plc. Its primary purpose is to ask shareholders to confirm how they wish to receive future shareholder communications, specifically mentioning the Annual Report and Accounts and dividends. It outlines three options for receiving notifications (Website & Email, Website & Letter, or Hard Copy by Post) and includes an election form. This document is not the Annual Report (10-K) itself, nor is it a specific financial result release (ER) or a formal proxy solicitation (PSI). Instead, it is an announcement about the *method* of future report delivery and soliciting an election from shareholders regarding communication preferences. This fits best under the category of a general announcement related to shareholder communications and corporate governance practices regarding document distribution, which aligns closely with the scope of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given that it is soliciting an election regarding how future reports (like the Annual Report) will be delivered, it is an announcement about the process of reporting rather than the report itself. Since it is a direct communication to shareholders about how they will receive future documents, RPA (Report Publication Announcement) is a strong candidate, as it announces the process surrounding the publication/delivery of reports. However, since the core action is soliciting an election on communication preferences, and it is not explicitly announcing the publication of a specific report, RNS (Regulatory Filings - fallback) or potentially CGR (Governance Information) could be considered. Given the context of managing shareholder communications and the election form, RPA seems the most specific fit as it relates directly to the delivery mechanism of reports. I will classify it as RPA because it is an announcement concerning the delivery/publication method of shareholder documents.
2022-05-12 English
Form of Proxy 2022
AGM Information Classification · 100% confidence The document text explicitly contains phrases like 'Annual General Meeting of Arix Bioscience plc is to be held on: Tuesday 7 June 2022', 'Arix Bioscience plc – Form of Proxy', and details regarding voting on resolutions, appointment of proxies, and attendance cards for the AGM. This content is directly related to the procedures and materials for an Annual General Meeting. Therefore, the classification is AGM-R (AGM Information).
2022-05-12 English
Notice of AGM 2022
AGM Information Classification · 99% confidence The document explicitly states 'NOTICE OF THE 2022 ANNUAL GENERAL MEETING' and contains a 'Letter from the Chairman' followed by the formal 'Notice of the Annual General Meeting' detailing resolutions to be voted on, including re-election of directors, auditor appointment, and authority to allot shares/purchase own shares. This content is characteristic of materials distributed to shareholders in advance of an AGM. The most specific category for this is AGM Information (AGM-R). Although it contains elements that might be in a Proxy Statement (like voting instructions), the primary purpose and title point directly to the AGM event itself.
2022-05-12 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.